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A monoclonal antibody, MANDYS141, binds to both dystrophin and actinin on Western blots (SDS-denatured), but only to actinin in frozen 
sections of human muscle (native conformation). It differs from a polyclonal cross-reacting antiserum in that it binds to several muscle isoforms 
of actinin (smooth, fast and slow) from man, mouse and chicken and recognises aquite different part of the proposed triple-helical region of dystro- 
phin (amino acids 1750-2248). The results suggest hat structural homologies between actinin and dystropbin occur more than once in their central 
helical regions and provide experimental support for an actinin-like centra1 rod model for dystrophin. 
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1. INTRODUCTION 
Dystrophin is a 427 kDa muscle membrane protein 
was obtained by digestion with PstI and Hind111 and cloned into 
pATH2, an expression vector containing part of the E. coii trpE gene 
inducible with indoleacrylic acid and tr~tophan starvation [S]. 
which is absent, reduced or altered as a result of muta- 
tion in the Duchenne muscular dystrophy (DMD) gene 
or its homologue (mdx) in the mouse [l]. Predictions 
from the sequence suggest a structural protein on the 
inner face of the membrane, consisting of a rod-shaped 
triple-helical domain separating an N-terminal actin- 
binding domain from two C-terminal domains, one of 
which is rich in cysteine [2]. A polyclonal rabbit an- 
tiserum raised against part of the proposed helical 
region (amino acids 1 lgl- 1388 in a recombinant fusion 
protein) of mouse cardiac dystrophin was found to 
cross-react with a fast skeletal muscle isoform of ac- 
tinin, even after affinity purification [1,3]. This cross- 
reaction was only obtained when native protein was us- 
ed as immunogen. More recently, an antiserum against 
dystrophin which reacts with the fast skeletal muscle 
isoform of C-protein has been described [4]. 
We now describe a monoclonal antibody, 
MANDYS141, raised against a quite different part of 
the central helical region of human skeletal muscle 
dystrophin, which cross-reacts with actinin from fast, 
slow and smooth muscle. 
Incfusion bodies were released from transforms and induced E. 
coli by sonication at 4°C in TNE buffer (SO mM NaCI, 1 mM EDTA, 
50 mM Tris-HCl, pH 8.0) and the 90 kDa fusion protein was partial- 
ly purified by gel filtration in 2% SDS buffer as described in [6]. Im- 
munization, fusion and hybridoma screening were performed as in 
[6]. MANDYSl41 belongs to the IgGZb subclass. 
2.2. Immuno~uores~ence microscopy 
7 Cm sections of human or mouse muscle frozen in isopentane were 
mounted on glass slides and stored at -70°C. Bound antibody was 
detected with FITC-labelled rabbit anti-(mouse Ig) (DAKO), using a 
Leitz Dialux microscope with epifluorescence optics and Ilford HP5 
film was exposed for 30 s. 
2.3. Cysfeine cleavage 
Cleavage of actinin by nitrothiocyanobenzoic acid in 5 M 
2. MATERIALS AND METHODS 
2.1. Preparation of immunogen and monoclonal antibodia 
A dystrophin cDNA fragment coding for amino acids’1750-2248 
guanidine-HCb’0.2 M Tris-acetate, pH 9.0, and subsequent analysis 
on 10% polyacrylamide gels was performed as previously described 
h71. 
2.4. Western blotting 
To minimise degradation, fresh minced muscle was dropped into 
4 ~01s of boiling extraction buffer (10% SDS, 10% EDTA, 5olo 
2-ME, 10% glycerol, 50 mM Tris-HCl, pH 6.7) [EJ, homogenised im- 
mediately in a Silverson blender, boiled again for 3 min and cen- 
trifuged (100 K, 20 min). After SDS-PAGE on 4-12.5070 gradient 
gels [l], protein bands were transferred to nitrocelhtlose overnight in 
25 mM Tris, 192 mM giycine either electrophoretically (BioRad 
Transbiot; 100 mA) or by diffusion. Blots were developed with 
monoclonal antibody cufture supernatants as described previously 
191. 
3. RESULTS 
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The monoclonal antibody, MANDYS141, binds to 
two major bands on Western blots of normal mouse 
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Fig. 1. Specificity of MANDYS141 antibody for dystrophin (DYS) and actinin (ACT). Additional faint bands indicated by * are non-specific 
reactions visible even when MANDYS141 is omitted (the smaller ones are mouse Ig chains reacting with the second antibody). Another band 
(- - -) may be actinin dimer. The second blot was produced by diffusion, rather than eiectrophoretically, so the high mofecular weight dystrophin 
was transferred less efficiently, It was cut down the middle of lane 6 for accurate alignment of protein bands and developed with rabbit anti-actinin 
serum (left half) or MANDYS141 (right half). 
muscle extracts at about 100 kDa and 400 kDa (Fig. 1, 
lane 1). The absence of the larger protein from extracts 
of dystrophic mouse (mdx) muscle (lane 2) confirms its 
identity as dystrophin. The 100 kDa protein, present in 
both normal and mdx mouse muscle, comigrates with 
the major protein in chicken breast muscle recognised 
by an antiserum raised against chicken gizzard actinin 
(Sigma; lanes 5, 6, 7). 
Immunolocalization in longitudinal sections of mdx 
mouse muscle supports the identification of the 
100 kDa protein as actinin; both MANDYSl41 
(Fig. 2a) and the anti-actinin serum (Fig. 2b) give the 
same pattern of narrow cross-striations, consistent with 
the Z-line location of actinin and similar to that observ- 
ed by Hoffman et al. [3] using a polyclonal anti- 
dystrophin/actinin serum. Monoclonality of the 
hybridoma line was ensured by two rounds of limiting 
dilution cloning at 0.5 cells per well or less. Several 
(4-8) hybridoma supernatants were tested after each 
cloning and all stained both proteins on Western blots. 
This rules out any possibility of there being two dif- 
ferent antibodies present in the culture supernatant. 
Although MANDYS141 recognises both ‘native’ ac- 
tinin in frozen sections and ‘denatured’ actinin on 
Western blots after SDS-PAGE, it does not recognise 
110. 
native dystrophin in frozen sections. Fig. 2c shows a 
transverse section of normal human muscle in which 
the antibody binds to all fibres internally without bin- 
ding to dystrophin in the membrane, unlike the 
polyclonal antiserum of Hoffman et al. which stains 
only fast fibres internally 131. (Fig. 2d shows typical 
dystrophin staining by a different monoclonal an- 
tibody, MANDYSI [6], which stains the same 400 kDa 
protein on Western blots.) A mosaic pattern of internal 
staining by MANDYS141 is sometimes observed, with 
some fibres more intensely stained than others, as in 
Fig. 2a for example, These quantitative, rather than 
qualitative, differences have not been sufficiently con- 
sistent to determine whether fast and slow fibres are in- 
volved. All sections in Fig. 2 did contain both fast and 
slow fibres as determined with an antibody against fast 
myosin and by differential ATPase staining [14]. 
We attempted to localise the epitope on actinin 
recognised by MANDYS141 by chemical cleavage of 
chicken gizzard actinin (Sigma) at Cys residues with 
nitrothiocyanobenzoic acid [7]. The antibody binds to 
actinin itself and only to one major fragment of about 
41 kDa (Fig. 3), although stained gels and blots (not 
shown) show that many other fragments, both larger 
and smaller, are available as predicted from actinin 
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Fig. 2. Immnnost~~~g of human and mouse muscle by rno~~~on~ 
antibodies. Frozen fongitudinal sections from mdx mouse thigb 
muscIe (a, b) or transverse sections from human muscle biopsies (c, 
d) were stained using monoclonal antibodies MANDYS141 (a, b, c) 
or the dystrophin-specific MANDYSl (d). Magnifications: a, b: 
Fig. 3. Binding of MANDYS141 to chicken smooth muscle (gizzard) 
actinin and to a 41 kDa cleavage product. Gizzard actinin (Sigma) 
before (-) and after (+) partial cleavage with ni~otb~ocyanob~zoj~ 
acid was subjected to SDS-PAGE on lUgr0 gets (with prestained blue 
I%& markers) and transferred to nitrocellulose by diffusion. Identical 
mirror-blots from the same gel were developed with MANDYS141 
(lanes 3, 4) or rabbit anti-actinin serum (lanes 5, 6; Sigma) as in 
1ooox; c, d: 400x. Fig. 1. 
an&i0 acid sequences [t 0, I I]. Predictably, apolyclonal 
antiserum binds to many more fragments, though it 
also fails to bind to any fragment smaller than 41 kDa 
(Fig. 3). Attempts to identify the 41 kDa fragment by 
N-terminal microsequencing (not shown) were unsuc- 
cessful, possibly because of amino-group modification 
after chemical cleavage. 
4. DISCUSSION 
Sequence similarities between dystrophin and actinin 
have been reported for both a&in-binding and cysteine- 
rich regions, but the sequence similarity of their helical 
domains is no greater than for many other proteins 
with a coiled-coil helical structure, such as spectrin and 
myosin. There are no identical linear stretches greater 
than three or four amino acids, though, on a higher 
level, there are signi~~t homologies in their helical 
repeat structures [la). Indeed, epitopes on triple-helical 
structures may consist of side-chains exposed on one 
face of a helix or they may even be shared between the 
surfaces of adjacent helices. Assembly of epitopes com- 
mon to dystrophin and actinin by protein folding in this 
way might expIain why they are not revealed by linear 
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sequence comparisons. Reaction on Western blots does 
not exclude an epitope assembled from distant amino 
acids in the linear sequence, since many antigens are 
capable of significant (though usually not complete) 
refolding during electrophoresis in 0.1% SDS [7,13]. 
MANDYS141 binds to native, myofibrillar actinin in 
frozen muscle sections but not to native dystrophin in 
the membrane. The opposite effect was observed with 
the Hoffman antiserum; good membrane and 
myofibrillar staining was obtained on muscle sections, 
but the antibody reacted weakly with dystrophin on 
Western blots relative to actinin [3]. One explanation is 
that the MANDYS141 epitope is obscured on native 
dystrophin, either by protein folding or by interaction 
with other proteins in the cell, while the epitope on ac- 
tinin is accessible in both conformations. Alternatively, 
MANDYS141 could have a high affinity for partially- 
denatured protein (on blots) but a low affinity for 
native protein (in frozen sections) and perhaps detect 
only the high abundance protein, actinin, in the latter 
case. In contrast, the Hoffman antiserum might have a 
lower affinity for denatured dystrophin and actinin 
than for the corresponding native proteins; this an- 
tiserum was obtained only when a soluble native form 
of immunogen was used [ 1,3], while MANDYS 141 was 
raised from an SDS-treated immunogen. 
Chemical cleavage results (Fig. 3) support an epitope 
assembled by protein folding rather than one formed 
by local folding of a linear amino acid sequence, since 
we might expect he latter to be present on a continuous 
‘ladder’ of partial digestion fragments [6,7]. It is not 
possible to identify the 41 kDa actinin fragment une- 
quivocally from the positions of Cys residues in the se- 
quence (although only part of chicken gizzard actinin 
has been sequenced irectly, it is thought o be the pro- 
duct of the same gene as fibroblast actinin [lo]). The 
largest predicted fragment after complete digestion 
would be Cys-480-Cys-768 (sequence of [lo]), or about 
33 kDa. This predicted fragment covers the major part 
of the helical region of actinin (residues 280-750) 
where the homology with our helical dystrophin frag- 
ment is expected to lie, but is too small to be the 41 kDa 
fragment in Fig. 3. Refolding of the MANDYS141 
epitope may require an intact chain at one or more of 
the Cys residues. 
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